Université Côte d'Azur
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
Previously recorded as Universite de Nice Sophia Antipolis (to 2022)
Previously recorded as Universite Nice Sophia Antipolis (to 2023)
0
Ending by 2030
May 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 18, 2026The maintenance fee for Biotechnological Manufacture of Vetiveryl Esters (US 10,323,210) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for System for Inspecting Surfaces of an Optical Wave Using a Graduated Density Filter (US 11,754,449) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
- 1 fee due Jun 19, 2027The maintenance fee for Heptane from a Plant Source, for the Extraction of Natural Products (US 11,845,720) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 19, 2026
- 1 term has ended since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,768,833 | Process for Multi-Analyses of Rare Cells Extracted or Isolated from Biological Samples Through Filtration In force · Low confidence | In force | Low confidence | |
| US 11,650,214 | Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 10,323,210 | Biotechnological Manufacture of Vetiveryl Esters In force · High confidence | In force | High confidence | |
| US 10,983,134 | Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 10,947,598 | Methods for Determining the Metabolic Status of Lymphomas In force · High confidence | In force | High confidence | |
| US 11,419,841 | New Uses of Lipophenolic Compounds In force · High confidence | In force | High confidence | |
| US 11,517,754 | Treatment of Type 1 Diabetes In force · High confidence | In force | High confidence | |
| US 12,723,234 | Method for the in Vitro or Ex Vivo Amplification of Human Adipose Tissue Stem Cells In force · Medium confidence | In force | Medium confidence | |
| US 10,917,109 | Methods for Storing Digital Data as, and for Transforming Digital Data into, Synthetic DNA In force · High confidence | In force | High confidence | |
| US 11,754,449 | System for Inspecting Surfaces of an Optical Wave Using a Graduated Density Filter In force · High confidence | In force | High confidence |
Also on record, not counted in the 18: 5 patents in force now held by others · 3 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
22 pending · 29 abandoned · 4 no status recorded